Specific Kinase Inhibitory Peptides for Use in Treatment of Cancer and Inflammatory Disorders
Inhibitors of Autophosphorylation Protein Kinases
None
Inventor: ZHANG, Meiyun
Priority Number: WO2011066721A1
IPC Current: C07K001628 | A61K003900 | A61K0039395 | C12N000518 | C12N001513
Assignee Applicant: The University of Hong Kong
Title: ANTL-IGF-IR ANTIBODIES AND USES THEREOF | ANTICORPS ANTI-IGF-IR ET LEURS UTILISATIONS
Usefulness: ANTL-IGF-IR ANTIBODIES AND USES THEREOF | ANTICORPS ANTI-IGF-IR ET LEURS UTILISATIONS
Summary: For treating a tumor or cancer in subject such as human, where the cancer is prostate cancer, breast cancer, liver cancer, or colon cancer (claimed).
Novelty: New isolated antibody that specifically binds to human insulin-like growth factor I receptor, useful for treating tumor or cancer e.g. prostate, breast or liver
诊断/治疗
癌症/肿瘤
Apr 19, 2004
7,189,694
美国
